Nestle's Vitamins Business Sale Should Lead to Minimal Earnings Dilution

Dow Jones
昨天

0619 GMT - Nestle's $1 billion deal to sell its mainstream vitamins, minerals and supplements business to private-equity group Yellow Wood Partners should result in a minimal dilution of the Swiss food giant's earnings, J.P. Morgan analysts say in a research note. The business generated roughly 1.1% of Nestle's sales last year and was a lower-margin part of the group's portfolio, according to JPM. Nestle will keep premium vitamins, minerals and supplements brands like Solgar and Pure Encapsulations. "The combination of the mainstream and premium [vitamins, minerals and supplements] businesses brought scale and breadth of brands that had manufacturing and [route-to-market] synergies that have since become less relevant, and Nestle has emphasized the strong performance of the premium [vitamins, minerals and supplements] business," the analysts say.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10